Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich fibrin injection plus microneedling versus saline injection plus microneedling for atrophic burn scars
IRCT20231209060308N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of platelet rich fibrin and Normal Saline-Benha University in burn scar and atrophic scar, sponsored by Iran University of Medical Sciences. Primary endpoint: Change in Patient and Observer Scar Assessment Scale. Started Feb 2024; status: completed.
02
Drugs
platelet rich fibrinNormal Saline-Benha University
03
Conditions
burn scaratrophic scar
Beyond the preview
Go deeper on IRCT20231209060308N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231209060308N1.